Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Thermo Fisher Expands Direct-to-Patient Service | Contract Pharma

What are you searching for?

Sign in
Breaking News

Thermo Fisher Expands Direct-to-Patient Service

Offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable medication delivery directly to patients' homes.

By: Contract Pharma

Contract Pharma Staff

Thermo Fisher Scientific has launched a newly expanded Direct-to-Patient service offering to support decentralized clinical trials that aims to minimize clinical trial length and costs and maximize patient enrollment and participation rates. The offering now includes Clinical Site-to-Patient, Pharmacy-to-Patient and Depot-to-Patient services to enable clinical trial medication delivery directly to patients’ homes.

Thermo’s expanded Direct-to-Patient services build on its global Clinical Site-to-Patient program that launched earlier this year to provide uninterrupted access to investigational drug shipments without having to visit a clinic. The program can support any trial phase and a range of trial variables including Interactive Response Technology (IRT) systems, blinded/unblinded and home nursing providers. Clinical Site-to-Patient services are available in 47 countries and have supported more than 1,500 shipments to patients worldwide to help treat more than 25 different indications.

“Decentralized clinical trials have been on the rise even before the COVID-19 pandemic due to the location of study centers and the amount of time required for study visits being barriers to patient enrollment and ongoing participation,” said Chris Armstrong, president, clinical trials business, Thermo Fisher Scientific. “As patients increasingly reach out to clinical trials sponsors to request receiving medication at home, it’s critical to have a solution that delivers patients’ medications safely and on time, without compromising trial quality and speed.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics